An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 7, 2007, Pages 684-692

  Stephen, Josena Kunjoonju ^a   Vaught, Lori E ^a   Kang, Mei Chen ^a   Shah, Veena ^a   Schweitzer, Vanessa G ^a   Gardner, Glendon ^a   Benninger, Michael S ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA EXTRACTION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE AMPLIFICATION; GENE PROBE; GENE SILENCING; HUMAN; HUMAN TISSUE; JUVENILE; LARYNGEAL BIOPSY; LARYNX PAPILLOMATOSIS; LIGATION; MALE; MICRODISSECTION; MOLECULAR CLONING; PAPILLOMA; PATHOGENESIS; PROMOTER REGION; RECURRENT DISEASE; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES, APC; GENES, P16; GLUTATHIONE S-TRANSFERASE PI; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR PROBE TECHNIQUES; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PROMOTER REGIONS (GENETICS); TISSUE INHIBITOR OF METALLOPROTEINASE-3; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 34447528979     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.7.684     Document Type: Article

References (64)

1. Bauman NM, Smith RJ. Recurrent respiratory papillomatosis. Pediatr Clin North Am. 1996;43(6):1385-1401.
2. Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12):1386-1391.
3. Kashima H, Mounts P, Leventhal B, Hruban RH. Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1993;102(8, pt 1):580-583.
4. Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J. 1998;17(5):372-376.
5. Schultz S, Trudeau M. Juvenile laryngeal papilloma: a review of etiology and treatment. Hearsay. 1988;2:30-32.
6. Armstrong L, Langston R. RRP Registry Update. Atlanta, GA: Centers for Disease Control and Prevention; 1998.
7. Erisen L, Fagan JJ, Myers EN. Late recurrences of laryngeal papillomatosis. Arch Otolaryngol Head Neck Surg. 1996;122(9):942-944.
8. Duggan MA, Lim M, Gill MJ, Inoue M. HPV DNA typing of adult-onset respiratory papillomatosis. Laryngoscope. 1990;100(6):639-642.
9. Doyle DJ, Henderson LA, LeJeune FE Jr, Miller RH. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg. 1994;120(11):1273- 1276.
10. Worsham MJ, Wolman SR, Zarbo RJ. Molecular genetic fingerprints: clues to monoclonal origin of multifocal disease. Mod Pathol. 1996;9(3):163-165.
11. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol. 1995;26(3):251-261.
12. Garcia SB, Park HS, Novelli M, Wright NA. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol. 1999;187(1):61-81.
13. Ha PK, Califano JA. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med. 2003;14(5):363-369.
14. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457-463.
15. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427-5440.
16. Nygren AO, Ameziane N, Duarte HM, et al. Methylation-specific MLPA (MSMLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005;33(14):e128.
17. Worsham MJ, Chen M, Muduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132(6):668-677.
18. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30(12):e57.
19. Worsham MJ, Pals G, Schouten JP, et al. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(7):702-708.
20. Kunjoonju JP, Raitanen M, Grenman S, Tiwari N, Worsham MJ. Identification of individual genes altered in squamous cell carcinoma of the vulva. Genes Chromosomes Cancer. 2005;44(2):185-193.
21. Worsham MJ, Pals G, Schouten JP, et al. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat. 2006;96(2):177-186.
22. Go C, Schwartz MR, Donovan DT. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Ann Otol Rhinol Laryngol. 2003;112(4):298-302.
23. Gupta D, Holden J, Layfield L. Topoisomerase alpha II, retinoblastoma gene product, and p53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis. Appl Immunohistochem Mol Morphol. 2001;9(1):86-91.
24. Lele SM, Pou AM, Ventura K, Gatalica Z, Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med. 2002;126(10):1184-1188.
25. Stern Y, Hurtubise PE, Cotton RT. Significance of DNA ploidy and cell proliferation in juvenile respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1998;107(10, pt 1):815-819.
26. INK4a is an early event in vulval squamous neoplasia. Oncogene. 2002;21 (12):1876-1881.
27. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci U S A. 1999;96(22):12754-12759.
28. Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672-1677.
29. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39:295-312.
30. Haber DA. Splicing into senescence: the curious case of p16 and p19ARF. Cell. 1997;91(5):555-558.
31. INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res. 1999;5(10):2704-2713.
32. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol. 2001;37(6):498-504.
33. Yeh KT, Chang JG, Lin TH, et al. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. Oncol Rep. 2003;10(3):659-663.
34. Uesugi H, Uzawa K, Kawasaki K, et al. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma. Int J Mol Med. 2005;15(4):597-602.
35. Eads CA, Lord RV, Kurumboor SK, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 2000;60(18):5021-5026.
36. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994;91 (21):9700-9704.
37. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis. J Clin Invest. 1998;101(6):1478-1487.
38. Qi JH, Ebrahem Q, Moore N, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med. 2003;9(4):407-415.
39. van der Laan WH, Quax PH, Seemayer CA, et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther. 2003;10(3):234-242.
40. Mohammed FF, Smookler DS, Taylor SE, et al. Abnormal TNF activity in Timp3. Nat Genet. 2004;36(9):969-977.
41. Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol. 2000;183 (2):145-154.
42. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61(8):3225-3229.
43. Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology. 2002;122(4):1113-1121.
44. Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 2001;61(8):3410-3418.
45. 2+/ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 1997;16(5):998-1008.
46. Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000;60(4):892-895.
47. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59 (1):67-70.
48. Lee TL, Leung WK, Chan MW, et al. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res. 2002;8(6):1761-1766.
49. Satoh A, Toyota M, Itoh F, et al. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer. 2002;86(11):1817-1823.
50. Dong SM, Kim HS, Rha SH, Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res. 2001;7(7):1982-1986.
51. Chopin V, Leprince D. Chromosome arm 17p13.3: could HIC1 be the one [in French]? Med Sci (Paris). 2006;22(1):54-61.
52. Rathi A, Virmani AK, Harada K, et al. Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms. Clin Cancer Res. 2003;9(10, pt 1):3674-3678.
53. Moscow JA, Townsend AJ, Goldsmith ME, et al. Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogenreceptor content in primary breast cancer. Proc Natl Acad Sci U S A. 1988;85(17):6518-6522.
54. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 1998;58(20):4515-4518.
55. Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A. 1994;91(24):11733- 11737.
56. Worsham MJ, Carey TE, Benninger MS, et al. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chromosomes Cancer. 1993;7(3):158-164.
57. Carey TE, Worsham MJ, Van Dyke DL. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J Cell Biochem Suppl. 1993;17F:213-222.
58. Carey TE, Van Dyke DL, Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res. 1993;13(6B):2561-2567.
59. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56(11):2488-2492.
60. Scholes AG, Woolgar JA, Boyle MA, et al. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res. 1998;58(9):2003-2006.
61. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol. 1997;33(5):332-337.
62. el-Naggar AK, Lai S, Luna MA, et al. Sequential p53 mutation analysis of preinvasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995;64(3):196-201.
63. Ribeiro U, Safatle-Ribeiro AV, Posner MC, et al. Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract. Surgery. 1996;120(1):45-53.
64. Lydiatt WM, Anderson PE, Bazzana T, et al. Molecular support for field cancerization in the head and neck. Cancer. 1998;82(7):1376-1380.